Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
Braz J Med Biol Res ; 39(2): 203-10, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16470307

RESUMEN

It has been suggested that iron overload may be carcinogenic. In the present study, we evaluated the effect of plasma and prostate carotenoid concentration on oxidative DNA damage in 12-week-old Wistar rats treated with intraperitoneal (ip) ferric nitrilotriacetate (Fe-NTA) (10 mg Fe/kg). Plasma beta-carotene and lycopene concentrations were measured as a function of time after ip injection of carotenoids (10 mg kg(-1) day(-1) beta-carotene or lycopene) in rats. The highest total plasma concentration was reached 3 and 6 h after ip injection of lycopene or beta-carotene, respectively. After 5 days of carotenoid treatment, lycopene and beta-carotene were present in the 0.10-0.51 nmol/g wet tissue range in the prostate. Using a sensitive method to detected 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo) by HPLC/EC, the level of 8-oxodGuo in rat prostate DNA was significantly higher (6.3 +/- 0.6 residues/10(6) dGuo) 3 h after Fe-NTA injection compared with control rats (1.7 +/- 0.3 residues/10(6) dGuo). Rats supplemented with lycopene or beta-carotene for 5 days prior to Fe-NTA treatment showed a reduction of about 70% in 8-oxodGuo levels to almost control levels. Compared with control rats, the prostate of Fe-NTA-treated animals showed a 78% increase in malondialdehyde accumulation. Lycopene or beta-carotene pre-treatment almost completely prevented lipid damage. Epidemiological studies have suggested a lower risk of prostate cancer in men reporting a higher consumption of tomato products. However, before associating this effect with tomato sauce constituents, more information is required. The results described here may contribute to the understanding of the protective effects of carotenoids against iron-induced oxidative stress.


Asunto(s)
Antioxidantes/análisis , Carotenoides/sangre , Daño del ADN/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Próstata/efectos de los fármacos , beta Caroteno/sangre , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Carcinógenos/farmacología , Carotenoides/análisis , Cromatografía Líquida de Alta Presión , ADN/química , ADN/efectos de los fármacos , Desoxiguanosina/análogos & derivados , Desoxiguanosina/análisis , Compuestos Férricos/farmacología , Licopeno , Masculino , Ácido Nitrilotriacético/análogos & derivados , Ácido Nitrilotriacético/farmacología , Próstata/química , Próstata/patología , Ratas , Ratas Wistar , beta Caroteno/análisis
2.
Braz. j. med. biol. res ; 39(2): 203-210, Feb. 2006. tab, graf
Artículo en Inglés | LILACS | ID: lil-420271

RESUMEN

It has been suggested that iron overload may be carcinogenic. In the present study, we evaluated the effect of plasma and prostate carotenoid concentration on oxidative DNA damage in 12-week-old Wistar rats treated with intraperitoneal (ip) ferric nitrilotriacetate (Fe-NTA) (10 mg Fe/kg). Plasma ß-carotene and lycopene concentrations were measured as a function of time after ip injection of carotenoids (10 mg kg-1 day-1 ß-carotene or lycopene) in rats. The highest total plasma concentration was reached 3 and 6 h after ip injection of lycopene or ß-carotene, respectively. After 5 days of carotenoid treatment, lycopene and ß-carotene were present in the 0.10-0.51 nmol/g wet tissue range in the prostate. Using a sensitive method to detected 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo) by HPLC/EC, the level of 8-oxodGuo in rat prostate DNA was significantly higher (6.3 ± 0.6 residues/10(6) dGuo) 3 h after Fe-NTA injection compared with control rats (1.7 ± 0.3 residues/10(6) dGuo). Rats supplemented with lycopene or ß-carotene for 5 days prior to Fe-NTA treatment showed a reduction of about 70 percent in 8-oxodGuo levels to almost control levels. Compared with control rats, the prostate of Fe-NTA-treated animals showed a 78 percent increase in malondialdehyde accumulation. Lycopene or ß-carotene pre-treatment almost completely prevented lipid damage. Epidemiological studies have suggested a lower risk of prostate cancer in men reporting a higher consumption of tomato products. However, before associating this effect with tomato sauce constituents, more information is required. The results described here may contribute to the understanding of the protective effects of carotenoids against iron-induced oxidative stress.


Asunto(s)
Animales , Masculino , Ratas , Antioxidantes/análisis , Carotenoides/sangre , Daño del ADN/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Próstata/efectos de los fármacos , beta Caroteno/sangre , Cromatografía Líquida de Alta Presión , Carcinógenos/farmacología , Carotenoides/análisis , ADN , Desoxiguanosina/análisis , Desoxiguanosina/análogos & derivados , Compuestos Férricos/farmacología , Ácido Nitrilotriacético/análogos & derivados , Ácido Nitrilotriacético/farmacología , Próstata/química , Próstata/patología , Ratas Wistar , beta Caroteno/análisis
3.
Arch Biochem Biophys ; 396(2): 171-7, 2001 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-11747294

RESUMEN

Experimental and epidemiological evidence suggests that lycopene, a carotenoid present in tomatoes, tomato products, and several fruits and vegetables, may play a role in preventing certain cancers in humans. We have investigated the effect of lycopene pretreatment on lipid peroxidation, oxidative damage to DNA, and histopathological changes in liver of animals subjected to intraperitoneal (ip) ferric nitrilotriacetate (Fe-NTA) administration. Compared with control rats, liver of Fe-NTA-treated animals showed a significant increase in the 8-oxo-7,8-dihydro-2'-deoxyguanosine level and a 75% increase in malondialdehyde accumulation concomitant with histopathological changes. Five days of lycopene pretreatment (10 mg/kg body weight, ip) almost completely prevented liver biomolecule oxidative damage and protected the tissue against the observed histological alterations.


Asunto(s)
Carcinógenos , Carotenoides/farmacología , Daño del ADN , ADN/efectos de los fármacos , Compuestos Férricos , Hígado/patología , Necrosis , Ácido Nitrilotriacético/análogos & derivados , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Anticarcinógenos/farmacología , Peso Corporal/efectos de los fármacos , Desoxiguanosina/análogos & derivados , Desoxiguanosina/biosíntesis , Peroxidación de Lípido , Hígado/efectos de los fármacos , Licopeno , Masculino , Malondialdehído/metabolismo , Malondialdehído/farmacología , Protectores contra Radiación/farmacología , Ratas , Ratas Wistar , Factores de Tiempo
4.
Arch Biochem Biophys ; 383(1): 56-9, 2000 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-11097176

RESUMEN

A high incidence of cancer has been correlated with chronic iron overload, and carotenoids are of interest as possible anticarcinogens. We have investigated the effect of lycopene on lipid peroxidation and on the formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo) in CV1-P monkey cells exposed to ferric nitrilotriacetate (Fe-NTA) plus ascorbate. Cells supplemented with lycopene (20 pmol/10(6) cells) showed a reduction of 86% in Fe-NTA/ascorbate-induced lipid peroxidation (TBARS). Levels of 8-oxodGuo rose from 1.59+/-0.09 residues/10(6) dGuo in the control cells to 14.02+/-0.41 residues/10(6) dGuo after incubation with (1:4 mM) Fe-NTA/ascorbate (40 microM). Lycopene supplementation decreased in 77% the 8-oxodGuo levels in Fe-NTA/ascorbate-treated cells. These results indicate that lycopene can protect mammalian cells against membrane and DNA damage and possibly play a protective role against tumor promotion associated with oxidative damage.


Asunto(s)
Antioxidantes/farmacología , Carotenoides/farmacología , Daño del ADN/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Antioxidantes/metabolismo , Ácido Ascórbico/farmacología , Carotenoides/metabolismo , Línea Celular , Desoxiguanosina/análogos & derivados , Desoxiguanosina/metabolismo , Compuestos Férricos/farmacología , Licopeno , Mutágenos/farmacología , Ácido Nitrilotriacético/análogos & derivados , Ácido Nitrilotriacético/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA